Skip to main content

Lynx1 Capital Management LP

Position in NEUP — Neuphoria Therapeutics Inc.

CIK 1910456 DORADO, PR

Position in NEUP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,825,183
+$262,599 QoQ
Shares Held
875,328
0.0% QoQ
Ownership
16.2%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1
of 22 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NEUP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lynx1 Capital Management LP holds $865,408,538 across 26 Biotechnology names. NEUP ranks #9 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEUP

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,825,183 875,328
2026-03-31 $3,562,584 875,328
2025-12-31 $3,395,884 875,228
2025-12-26 $3,256,220 875,328
2025-12-02 $3,825,183 875,328
2025-11-28 $3,956,482 875,328
2025-11-18 $4,149,054 875,328
2025-11-09 $3,588,844 875,328
2025-10-21 $4,245,340 875,328
2025-06-30 $325,222 45,806
2025-03-31 $263,842 45,806
2024-12-31 $157,114 45,806